Dr. Bassem Chehab
Claim this profileCardiovascular Research Institute of Kansas
Studies Mitral Regurgitation
Studies Mitral Valve Regurgitation
21 reported clinical trials
31 drugs studied
About Bassem Chehab
Education:
- Earned an MD from Lebanese University, Beirut, Lebanon.
- Completed Internal Medicine Residency at the University of Kansas School of Medicine.
- Undertook Cardiovascular Medicine and Structural Interventional Cardiology Fellowships at the University of Kansas Medical Center.
Experience:
- Served as Chief Resident during Internal Medicine Residency and Chief Fellow during Cardiovascular Medicine Fellowship at the University of Kansas.
- Currently the Director of Structural Cardiology and Hybrid Operating Room programs at Via Christi Hospitals in Wichita.
- Affiliated with Cardiovascular Consultants of Kansas, contributing to pioneering work in Transcatheter Aortic Valve Replacement (TAVR) and Left Atrial Appendage closure.
Affiliated Hospitals
Clinical Trials Bassem Chehab is currently running
Cephea Valve System
for Mitral Regurgitation
This trial is testing a new device called the Cephea Mitral Valve System that can fix or replace a damaged heart valve using a thin tube. It aims to help patients with mitral valve disease who need a less invasive treatment than open-heart surgery. The Cephea Mitral Valve System is a new technology developed by Cephea Valve Technologies, aiming to treat severe mitral regurgitation through a less invasive approach.
Recruiting1 award N/A
Aortix Device
for Heart Failure
This trial tests a device called Aortix that helps the heart pump blood better. It targets patients with severe heart failure who don't get better with usual treatments. The device works by helping the heart move blood more efficiently.
Recruiting1 award N/A5 criteria
More about Bassem Chehab
Clinical Trial Related3 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Bassem Chehab has experience with
- MitraClip G4 System
- MitraClip™ Device Implantation
- Mitral Valve Repair Surgery
- ABT NG DES 48
- CardioMech MVRS
- Neovasc Reducer System
Breakdown of trials Bassem Chehab has run
Mitral Regurgitation
Mitral Valve Regurgitation
Heart Failure
Valvular Heart Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bassem Chehab specialize in?
Bassem Chehab focuses on Mitral Regurgitation and Mitral Valve Regurgitation. In particular, much of their work with Mitral Regurgitation has involved Stage III patients, or patients who are undergoing treatment.
Is Bassem Chehab currently recruiting for clinical trials?
Yes, Bassem Chehab is currently recruiting for 9 clinical trials in Wichita Kansas. If you're interested in participating, you should apply.
Are there any treatments that Bassem Chehab has studied deeply?
Yes, Bassem Chehab has studied treatments such as MitraClip G4 System, MitraClip™ device implantation, Mitral Valve Repair Surgery.
What is the best way to schedule an appointment with Bassem Chehab?
Apply for one of the trials that Bassem Chehab is conducting.
What is the office address of Bassem Chehab?
The office of Bassem Chehab is located at: Cardiovascular Research Institute of Kansas, Wichita, Kansas 67226 United States. This is the address for their practice at the Cardiovascular Research Institute of Kansas.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.